Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone
Hl. Chenoufi et al., Increased mRNA expression and protein secretion of interleukin-6 in primary human osteoblasts differentiated in vitro from rheumatoid and osteoarthritic bone, J CELL BIOC, 81(4), 2001, pp. 666-678
We have investigated the expression and synthesis of potential bone-resorbi
ng cytokines, interleukin-6 (IL-6), interleukin-1 (IL-1), and tumor necrosi
s factor (TNF) in rheumatoid arthritic (RA) and osteoarthritic (OA) bone, t
wo common diseases which are associated with bone loss. Primary human osteo
blast (hOB) cultures were established to determine the temporal mRNA expres
sion of IL-6, IL-1 (alpha and beta), and TNF (alpha and beta) in relation t
o osteoblast growth and phenotypic genes. IL-6 mRNA levels were found to be
significantly higher (P < 0.04) in both OA hOB (17 patients) and RA hOB (1
0 patients) compared to normal (NO) hOB (9 patients) and reached five-fold
increases in OA hOB and 13-fold increases in RA hOB. Maximal levels of IL-6
are expressed at Day 21 which corresponds to the mineralization stage refl
ected by decreasing collagen I (<alpha>(1)), osteopontin, bone sialoprotein
, alkaline phosphatase mRNA levels, while osteocalcin (OC) mRNA levels incr
eased. IL-6 protein levels also were significantly higher (P < 0.05) in OA
hOB and RA hOB compared to NO hOB. These increases were not attributable to
sex or age of the donor bone. Neither the mRNA encoding IL-1(<alpha> and b
eta) and TNF(alpha and beta) nor the related proteins were detectable. Thes
e results indicate that differentiated OA hOB and RA hOB within a bone tiss
ue-like matrix constitutively express and secrete high levels of IL-6. This
inherent property suggests that these osteoblasts, independent of local in
flammatory parameters, can contribute to enhanced recruitment of osteoclast
progenitors and thereby bone resorption. J. Cell. Biochem. 81:666-678, 200
1. (C) 2001 Wiley-Liss, Inc.